Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vistagen Therapeutics (VTGN) Other Non Operating Income (2017 - 2025)

Historic Other Non Operating Income for Vistagen Therapeutics (VTGN) over the last 6 years, with Q3 2025 value amounting to $6000.0.

  • Vistagen Therapeutics' Other Non Operating Income changed N/A to $6000.0 in Q3 2025 from the same period last year, while for Dec 2025 it was $9000.0, marking a year-over-year change of. This contributed to the annual value of $5000.0 for FY2025, which is 9839.74% down from last year.
  • According to the latest figures from Q3 2025, Vistagen Therapeutics' Other Non Operating Income is $6000.0.
  • In the past 5 years, Vistagen Therapeutics' Other Non Operating Income registered a high of $6000.0 during Q3 2025, and its lowest value of -$2000.0 during Q2 2025.